InvestorsHub Logo
Followers 20
Posts 1107
Boards Moderated 0
Alias Born 08/28/2012

Re: martin33 post# 10368

Sunday, 09/08/2013 8:27:58 AM

Sunday, September 08, 2013 8:27:58 AM

Post# of 24848
Yes, the Pediatric RapiMeds launch was delayed and is now set for Q4 2013 (see ScripsAmerica website news). Delays aren't uncommon when launching a new product to the market. All the dedicated "Longs" are still intact and see this time as a tremendous buying opportunity. Even when I bought in last March I was told this was a long term investment with the greatest returns to come in 2014 when the revenues are at full swing. The distribution line is established and during the last couple months and Bob Schneiderman has sign a couple additional joint ventures with reputable wholesale pharmacy networks (check out SCRC news). I am confident Bob will finalize all the financing details and when that occurs SCRC will move forward with production and distribution. The PPS will reflect all this positive activity and these teens and twenties will be a thing of the past. I truly believe when SCRC hits the $1 mark it will be sustained by strong revenues and not influenced by the fly by night pump and dumpers, these too will be a thing of the past. A solid company, a real product, a strong distribution line, and a dedicated CEO, equates to a profitable future. Believe what you to believe and say what you want to say, but I am focused on SCRC's long term 2014 success.